Mucosal Vaccination for Influenza Protection Enhanced by Catalytic Immune‐Adjuvant

Abstract Influenza poses a severe threat to global health. Despite the whole inactivated virus (WIV)‐based nasal vaccine being a promising strategy for influenza protection, the mucosal barrier is still a bottleneck of the nasal vaccine. Here, a catalytic mucosal adjuvant strategy for an influenza W...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Tao Qin, Shang Ma, Xinyu Miao, Yan Tang, Dandan Huangfu, Jinyuan Wang, Jing Jiang, Nuo Xu, Yuncong Yin, Sujuan Chen, Xiufan Liu, Yinyan Yin, Daxin Peng, Lizeng Gao
Format: Artigo
Langue:Inglês
Publié: Wiley 2020-09-01
Collection:Advanced Science
Sujets:
adjuvant
influenza virus
mucosal vaccine
nanozyme
Accès en ligne:https://doi.org/10.1002/advs.202000771
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires